Breakwater Capital Group grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 50.7% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 3,337 shares of the exchange traded fund’s stock after purchasing an additional 1,123 shares during the quarter. Breakwater Capital Group’s holdings in SPDR S&P Biotech ETF were worth $309,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. ICA Group Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF in the 4th quarter worth approximately $27,000. Scarborough Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the 4th quarter worth about $32,000. BOCHK Asset Management Ltd purchased a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $36,000. ORG Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $40,000. Finally, Vima LLC bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $45,000.
SPDR S&P Biotech ETF Price Performance
SPDR S&P Biotech ETF stock traded down $0.53 during midday trading on Wednesday, reaching $100.54. 5,006,452 shares of the company traded hands, compared to its average volume of 9,987,026. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The business has a 50 day moving average of $96.55 and a two-hundred day moving average of $93.41. The firm has a market capitalization of $7.66 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- What Are Growth Stocks and Investing in Them
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- How to Start Investing in Real Estate
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.